News

Disappearing into thin air: harnessing oxygen drop could eliminate cancers without harming healthy tissue

A major advance towards targeting cancer without harming healthy tissue has been discovered by University of Bristol researchers. The team has found a way to exploit hypoxia (reduced oxygen levels) — a condition which occurs during the development of many common cancers and drives their progression and spread. The findings, which have implications for targeted oncology, are published today [24 August 2018] in the journal EMBO Molecular Medicine.

First in human study to assess knee cartilage repair implant launches at Southmead Hospital

A new first in human study to assess the safety and performance of FibroFix Cartilage P™ (FibroFix™), an innovative implant that repairs knee cartilage, is starting at Southmead Hospital, Bristol. The FFLEX clinical trial has been awarded nearly £1.2million by the National Institute for Health and Care Research (NIHR) and will be led by Orthox, the company behind FibroFix™, and researchers from the University of Bristol.

People from low socioeconomic backgrounds could reduce chronic kidney disease risk with regular exercise, study suggests

New research has found people from lower socioeconomic backgrounds who regularly exercise could substantially reduce their risk of chronic kidney disease. Chronic kidney disease is linked to poor quality of life and an increased risk of death. Its treatment is also associated with high healthcare costs, with diabetes and high blood pressure major factors that contribute to the disease.